EdgarLookup

Neumora Therapeutics, Inc. — DEFA14A Filings

3 DEFA14A filings on record

This page lists all DEFA14A filings submitted to the SEC by Neumora Therapeutics, Inc. (NMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Neumora Therapeutics, Inc. has filed 3 DEFA14A documents with the SEC since 2021. To view all SEC filings by Neumora Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 424B4 8-A12B 8-K 8-K/A CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT POS AM POSASR PRE 14A S-1 S-1/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
DEFA14A DEFA14A 0001193125-25-121717 May 16, 2025 —
DEFA14A DEFA14A 0000950170-25-060098 Apr 29, 2025 —
DEFA14A DEFA14A 0000950170-24-048333 Apr 25, 2024 —